Pharmanutra S.p.A. (BIT:PHN)
Italy · Delayed Price · Currency is EUR 89.40
+3.10 (3.59%)
May 28, 2026, 5:35 PM CET
Pharmanutra Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Pharmanutra stock has a consensus rating of "Strong Buy" and an average price target of €94.33. The average 1-year stock price forecast is 5.51% higher than the current stock price, while the lowest is €92.00 (+2.91%) and the highest is €98.00 (+9.62%).
Price Target: €94.33 (+5.51%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pharmanutra stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Berenberg Bank No rating | Berenberg Bank | Buy Maintains €85.00 → €93.00 | Buy | Maintains | €85.00 → €93.00 | +4.03% | May 13, 2026 |
| Intermonte | Intermonte | Buy Maintains €89.00 → €98.00 | Buy | Maintains | €89.00 → €98.00 | +9.62% | May 12, 2026 |
| TP ICAP MIDCAP | TP ICAP MIDCAP | Buy Reiterates €74.00 | Buy | Reiterates | €74.00 | -17.23% | Feb 3, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.